Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Havn Life Sciences Inc (OP: HAVLF )

0.0236 UNCHANGED
Streaming Delayed Price Updated: 1:21 PM EDT, May 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Havn Life Sciences Inc

< Previous 1 2 Next >
HAVN Life is Looking for a Safe Haven to Mental Health Through Psychedelic Medicine
Most companies' success stories come as a result of wanting to accomplish a greater purpose. For HAVN Life Sciences Inc. (CSE: HAVN) (OTC PINK: HAVLF) (FSE: 5NP) CEO Tim Moore... 
Via Benzinga
HAVN Life Announces Retail Partnership with Grocer, Choices Markets
Newly-launched line of natural health products to be available at all locations later this month VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP)... 
From Havn Life Sciences Inc.
Via AccessWire
HAVN Life Launches New Line of Natural Health Products
Seven New Formulations That Support Brain Health and Immune Function Will Be Available Online and at Select Retail Locations Starting June 3 VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / HAVN Life... 
From Havn Life Sciences Inc.
Via AccessWire
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
The Company will seek Orphan Drug Designation to significantly reduce time to market VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the... 
From Havn Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Amanita Muscaria: A Legal Psychoactive Mushroom With Potential Therapeutic Effects
Amanita Muscaria is an understudied species of psychoactive mushroom that’s as commonplace as it is misunderstood. The iconic red-c... 
Via Benzinga
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index. 
Via Talk Markets
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings
Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the... 
From Havn Life Sciences Inc.
Via AccessWire
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass Pa... 
Via Benzinga
Exposures Product Safety
The Miracle Compound Tackling A Trillion Dollar Crisis
Via FinancialNewsMedia
Exposures COVID-19
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
HAVN Life works towards substantiating a patent application and preclinical work VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company"... 
From Havn Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
Havn Life will join 80+ other small cap and micro-cap companies at leading event for investors VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP)... 
From Havn Life Sciences Inc.
Via AccessWire
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC... 
From Havn Life Sciences Inc.
Via AccessWire
Topics Supply Chain
Exposures Supply Chain
Havn Life Develops New Method for Rapid Psilocybin Testing
Havn Life has completed its analytical work under its Health Canada Section 56 exemption VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the... 
From Havn Life Sciences Inc.
Via AccessWire
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound... 
Via Benzinga
Havn Labs Jamaica Facility Now Fully Operational
The Company has started production of its first grow with local partner Hypha Wellness VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the... 
From Havn Life Sciences Inc.
Via AccessWire
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027
Via FinancialNewsMedia
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
Exposures Cannabis
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. VANCOUVER, BC / ACCESSWIRE / April 8, 2021 / Havn Life Sciences Inc.... 
From Havn Life Sciences Inc.
Via AccessWire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.